March 4, 2015— The American Association for Cancer Research (AACR) is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Translational Research Grant. The grant provides up to $12 million over a three-year period for research on prevention, diagnosis, or treatment of pancreatic cancer by a “Dream Team” of top scientists.
SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Supports New Immunotherapy TrialFebruary 26, 2015 - Aduro Biotech, Inc. today announced the initiation of an investigator-sponsored Phase 2 clinical trial of the company’s immuno-oncology product candidates GVAX Pancreas and CRS-207 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab), a monoclonal antibody against programmed death-1 receptor (PD-1).
February 4, 2015 -- WETA, the flagship public media station for Washington, D.C., announced today, World Cancer Day, that it has produced a 30-minute television special titled Cancer: The Emperor of All Maladies — A Conversation.
February 2, 2015 — A total of $1 million has been awarded to four teams of cancer researchers from Stand Up To Cancer (SU2C) to encourage accelerated or elevated collaboration and innovation among SU2C-supported researchers.
January 29, 2015 – At last night’s Hollywood Stands Up To Cancer fundraising event, Stand Up To Cancer (SU2C) Co-Founder Katie Couric recognized MasterCard as a SU2C Visionary, a small group of donors who have each contributed more than $25 million. MasterCard then announced its new commitment of $10 million to support SU2C’s innovative cancer research programs.